Nicotine Pouch Startup Sesh Raises $40 Million, Backed by 8VC and Celebrity Investors

Sep.05.2025
Nicotine Pouch Startup Sesh Raises $40 Million, Backed by 8VC and Celebrity Investors
U.S. nicotine pouch startup Sesh has secured $40 million in funding, led by 8VC, with contributions from Post Malone, Diplo, and Andrew Schulz. The company, co-developed by Zyn inventor Thomas Ericsson, has submitted a marketing application to the FDA and is permitted to operate in the U.S. market. Sesh, now headquartered in Austin, has about 30 employees and its products are available in over 5,000 stores across the U.S. and Canada.

Key Points:

 

·Financing: Sesh secured $40 million in funding, led by 8VC and with participation from several prominent investors.
·Product Development: Sesh's products were co-developed by Thomas Ericsson, the inventor of Zyn.
·Regulatory Updates: Sesh has submitted its marketing application to the FDA and has been approved for operation in the US market.
·Market Coverage: Sesh's products are available in over 5,000 retail stores in the US and Canada.
·Company Development: Sesh has relocated its headquarters to Austin and employs approximately 30 full-time employees.

 


 

2Firsts, September 4, 2025,-Yahoo Finance, citing Fortune, reported that U.S.-based nicotine pouch startup Sesh has raised $40 million in funding. The round was led by venture capital firm 8VC, with participation from musicians Post Malone and Diplo, as well as comedian Andrew Schulz.

 

According to its official website, 8VC is a venture capital firm based in Austin, Texas, focusing on transformational technologies in sectors such as infrastructure IT, biotech, healthcare, defense, and logistics.

 

Nicotine Pouch Startup Sesh Raises $40 Million, Backed by 8VC and Celebrity Investors
Image source: 8VC official website

 

According to the report, Sesh’s product was developed with involvement from Thomas Ericsson, the inventor of Zyn. The company has submitted a marketing application to the U.S. Food and Drug Administration (FDA) and is currently allowed to operate in the U.S. market.

 

In early 2025, the FDA approved several Zyn products for marketing, including flavored variants, signaling a regulatory pathway for other nicotine pouch companies with pending applications.

 

Sesh has relocated its headquarters to Austin. The company currently employs around 30 full-time staff and its products are available in over 5,000 retail stores across the U.S. and Canada.

 

Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Product | PIXL Adds 6ml PIXL 5K in UK Alongside 12ml PIXL 8000 as Vape Duty Takes Effect
Vaping brand PIXL has introduced the PIXL 5K reusable prefilled pod device in the UK, featuring a 2ml prefilled pod and a 4ml refill container with a combined e-liquid capacity of 6ml. The device uses 20mg/ml nicotine salt e-liquid and is advertised to deliver up to approximately 5,000 puffs. Available through UK retailers by August 2026, the PIXL 5K sits alongside the existing 12ml PIXL 8000. The UK's Vaping Products Duty took effect on October 1 at £0.22 per millilitre, producing theoretical duty amounts of £1.32 and £2.64 for the two products' respective full refill sets.
product
Oct.10
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup Tracks Nicotine Pouch Use for the First Time: 11% of U.S. Adults Smoke, 9% Vape and 4% Use Nicotine Pouches
Gallup’s 2026 Consumption Habits survey tracked nicotine pouch use for the first time. The survey found that 11% of U.S. adults reported smoking cigarettes in the past week, 9% reported vaping, and 4% reported using nicotine pouches. Cigarette smoking remained near Gallup’s long-term low, while adult vaping rates stayed relatively stable in recent years.
Market
Aug.25 by 2Firsts Perspectives
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22